Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMIUM pre-surgical metformin study in uterine malignancies
ISRCTN88589234Phase 3Completed
- Sponsor
- Central Manchester and Manchester Children's Hospitals NHS Trust
- Start
- Feb 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in endometrial cancer (EC) and Endometrial intraepithelial neoplasia (EIN) comparing Metformin with Placebo (2 arms). Primary endpoint: Tumor Ki-67 analysis. Started Feb 2015; status: completed.
02
Drugs
metformin
03
Conditions
endometrial cancer (EC)Endometrial intraepithelial neoplasia (EIN)
Beyond the preview
Go deeper on ISRCTN88589234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN88589234.